Han Y - Search Results

1

ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand.

Han Y, Chen J, Chopra VK, Zhang S, Su G, Ma C, Huang Z, Ma Y, Yao Z, Yuan Z, Zhao Q, Kuanprasert S, Baccara-Dinet MT, Manvelian G, Li J, Chen R. Han Y, et al. J Clin Lipidol. 2020 Jan-Feb;14(1):98-108.e8. doi: 10.1016/j.jacl.2019.10.015. Epub 2019 Nov 18. J Clin Lipidol. 2020. PMID: 31882376 Free article. Clinical Trial.

2

[Coronary intervention in 1148 patients with chronic total coronary occlusion].

Han YL, Zhang J, Jing QM, Wang SL, Ma YY, Luan B, Li Y. Han YL, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Apr;33(4):299-302. Zhonghua Xin Xue Guan Bing Za Zhi. 2005. PMID: 15932654 Chinese.

3

RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.

Ge J, Han Y, Jiang H, Sun B, Chen J, Zhang S, Du Z; RACTS (Randomized Prospective Antiplatelet Trial of Cilostazol Versus Ticlopidine in Patients Undergoing Coronary Stenting) Trial Investigators. Ge J, et al. Among authors: han y. J Cardiovasc Pharmacol. 2005 Aug;46(2):162-6. doi: 10.1097/01.fjc.0000167012.82930.8f. J Cardiovasc Pharmacol. 2005. PMID: 16044027 Clinical Trial.

4

[Effects of cilostazol on long-term clinical outcomes after coronary stenting].

Han YL, Wang SL, Li Y, Jing QM, Ma YY, Deng J, Yang GT, Yu HB, Ge JB. Han YL, et al. Zhonghua Nei Ke Za Zhi. 2005 Nov;44(11):814-7. Zhonghua Nei Ke Za Zhi. 2005. PMID: 16316558 Clinical Trial. Chinese.

5

[Comparison of Rapamycin and Paclitaxel eluting stent in patients with multi-vessel coronary disease].

Han YL, Wang XZ, Jing QM, Wang SL, Ma YY, Luan B. Han YL, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Feb;34(2):123-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 16626577 Clinical Trial. Chinese.

6

[Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].

Han YL, Su QF, Li Y, Wang SL, Jing QM, Ma YY, Wang ZL, Wang DM, Luan B. Han YL, et al. Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1093-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16796832 Clinical Trial. Chinese.

7

[Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].

Han YL, Deng J, Jing QM, Wang SL, Ma YY, Luan B. Han YL, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jun;34(6):483-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 16842659 Chinese.

8

Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center report.

Han YL, Wang SL, Jing QM, Li Y, Zhang J, Ma YY, Luan B. Han YL, et al. Chin Med J (Engl). 2006 Jul 20;119(14):1165-70. Chin Med J (Engl). 2006. PMID: 16863607

9

[Clinical characteristics and management of patients with acute or subacute coronary in-stent thrombosis].

Han YL, Liang M, Jing QM, Wang SL, Ma YY, Luan B. Han YL, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Nov;34(11):975-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 17288755 Chinese.

10

Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions.

Han YL, Wang SL, Jing QM, Yu HB, Wang B, Ma YY, Luan B, Wang G. Han YL, et al. Chin Med J (Engl). 2007 Apr 5;120(7):552-6. Chin Med J (Engl). 2007. PMID: 17442201 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26,207 results

Search Page